Quest Diagnostics (DGX) Minority Interest (2009 - 2026)

Quest Diagnostics (DGX) has 18 years of Minority Interest data on file, last reported at $300.0 million in Q1 2026.

• Quarterly Minority Interest rose 809.09% year-over-year to $300.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $300.0 million (up 809.09% YoY) and the FY2025 annual result came in at $36.0 million, up 2.86% from the prior year.
• Minority Interest rose to $300.0 million in Q1 2026 per DGX's latest filing, from $36.0 million in the prior quarter.
• The five-year high for Minority Interest was $300.0 million in Q1 2026, with the low at $33.0 million in Q1 2025.
• Average Minority Interest over 5 years is $71.5 million, with a median of $76.0 million recorded in 2023.
• Year-over-year, Minority Interest sank 57.14% in 2025 and soared 809.09% in 2026.
• Quest Diagnostics' Minority Interest stood at $77.0 million in 2022, then fell by 1.3% to $76.0 million in 2023, then tumbled by 53.95% to $35.0 million in 2024, then increased by 2.86% to $36.0 million in 2025, then surged by 733.33% to $300.0 million in 2026.
• Business Quant data shows DGX's Minority Interest at $300.0 million in Q1 2026, $36.0 million in Q4 2025, and $81.0 million in Q3 2025.